期刊文献+

肾移植围术期少尿的血液透析治疗

Hemodialysis treatment for oliguric patients during kidney transplantation
下载PDF
导出
摘要 目的:总结异体肾移植围术期少尿患者血液透析治疗效果。方法:我院自1995年5月~2005年5月行异体肾移植术,围术期少尿或无尿患者34例,给予血液透析及调整免疫抑制剂,抗炎、川芎嗪等治疗。结果:移植肾术后早期少尿或无尿患者原因,急性排斥反应55.9%,急性肾小管坏死38.2%,加速排斥反应5.9%。肾功能恢复31例,治愈率91.1%,3例移植肾切除,死亡1例,死亡原因是加速排斥反应。尿量恢复时间,最短术后7d,最长术后5个月,急性肾小管坏死组尿量恢复(15.4±8.3)d,急性排斥组尿量恢复(25.7±4.3)d。结论:合理血液透析治疗可减少并发症,提高人/肾治愈率,避免肾功能延迟恢复。 Objective To summarize the treatment effect of hemodialysis on oliguric patients during xenogenic kidney transplantation. Method 34 oliguric or anuric patients in the period of xenogenic kidney transplantation who was in-hospital between May 1995 and May 2005 were given hemodialysis, immunosuppressive agent, antiinflammatory drug, ligustrazine and so on. Results The reasons that led to oliguria or anuria early after transplantation were acute rejective reaction (55.9%), acute renal tubular necrosis (38.2%) and accelerated rejective reaction (5.9%). After kidney transplantation, 31 cases' kidney function recovered and the cure rate was 91.9%, 3 cases of transplanted kidney excised and 1 case died with the reason of accelerated rejective reaction. The urine volume recovery time were from 7 days to 5 months and in the acute renal tubular necrosis group was (15.4±8.3) days, in the acute rejection group was (25.7±4.3) days. Conclusion Reasonable hemodialysis treatment can reduce complications, improve the cure rate of human/kidney and avoid delayed recovery of kidney function.
出处 《吉林医学》 CAS 2006年第11期1347-1348,共2页 Jilin Medical Journal
关键词 肾脏移植 急性肾功能衰竭 血液透析 Kidney transplantation Acute kidney function failure Hemodialysis
  • 相关文献

参考文献8

二级参考文献32

  • 1樊光辉,肖创青,陈菊梅,彭方,叶金玉.川芎嗪对冠心病患者血脂质过氧化物等含量的影响[J].中国中西医结合杂志,1994,14(1):26-27. 被引量:90
  • 2易著文,孙林.人胎肾小球系膜细胞产生与表达白介素-6[J].肾脏病与透析肾移植杂志,1994,3(5):359-361. 被引量:6
  • 3唐利龙,汪丽惠,朱国英,张均华.川芎嗪和肝素对原代培养血管平滑肌细胞生长和分裂的影响[J].中国中西医结合杂志,1995,15(1):38-39. 被引量:50
  • 4Lai K N,Am J Kidney Dis,1996年,28卷,5期,721页
  • 5Le meur Y,Lorgeot V,Aldigier J-C et al.Whole blood production of monocytic cytokines(IL-1β,IL-6,TNF-α,sIL-6R,IL-1Ra)in haemodialysed patients .Nephrol Dial Transplant,1999,14:2420
  • 6Girndt M,Lengler S,Kaul H et al.Prospective crossover trial of the influence of vitamin E-coated dialyzer membranes on T-cell activation and cytokine induction.Am J Kidney Dis,2000,35:95
  • 7Carracedo J,Ramirez R,Madueno JA et al.Cell apoptosis and hemodialysis-induced inflammation.Kidney Int,2002,61(Suppl 80):89
  • 8Lonnemann G.Chronic inflammation in hemodialysis:The role of contaminated dialysate.Blood Purify,2000,18:214
  • 9Balakrishnan VS,Jaber BL,Natov SN et al.Interleukin-1 receptor antagonist synthesis by peripheral blood mononuclear cells in hemodialysis patients.Kidney Int,1998,54:2106
  • 10Kimmel PL,Philips TM,Simmens SJ et al.Immunologic function and survival in hemodialysis patients.Kidney Int,1998,54:236

共引文献301

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部